ArticleJournal for immunotherapy of cancer2024

Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy.

Hesong Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.